FDA Inspection
E2P4 LabsE2P4 Labs – FDA Inspection, Sep 17, 2024
Record Details
This FDA Inspection record concerns E2P4 Labs, with an inspection on September 17, 2024, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 91e794df-cc3c-41c1-aae0-87b694efe73b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1250451
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.55(b)(3)Name and address on summary
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.